Advertisement

Common Cold pp 23-45 | Cite as

Mechanisms of symptoms of common cold and flu

  • Ronald Eccles
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)

Abstract

It is the familiar symptoms of sore throat, runny nose, sneezing, and nasal congestion, muscle aches, chilliness and fever, etc., that define the common cold and flu syndromes as self-diagnosed illnesses. Although there is much information about the molecular biology of the viruses that cause the common cold and flu syndromes, there is relatively little research on the immunological, physiological and pathophysiological mechanisms involved in generating the symptoms. This chapter studies the mechanisms that cause local symptoms associated with local inflammation of the airway (sore throat, sneezing, rhinorrhoea and purulent nasal discharge, nasal congestion, sinus pain, watery eyes and cough), and the mechanisms that cause systemic symptoms associated with release of cytokines from leukocytes (headache, chilliness and fever, psychological effects, malaise and mood changes, loss of appetite, and muscle aches and pains).

Keywords

Sore Throat Common Cold Nasal Congestion Nasolacrimal Duct Sickness Behaviour 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eccles R (2005) Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5: 718–725.CrossRefPubMedGoogle Scholar
  2. 2.
    Jackson G, Dowling H, Spiesman I, Boand A (1958) Transmission of the common cold to volunteers under controlled conditions. 1. The common cold as a clinical entity. Arch Intern Med 101:267–278Google Scholar
  3. 3.
    Heikkinen T, Jarvinen A (2003) The common cold. Lancet 361:51–59.CrossRefPubMedGoogle Scholar
  4. 4.
    Tyrrell DA, Cohen S, Schlarb JE (1993) Signs and symptoms in common colds. Epidemiol Infect 111: 143–156CrossRefPubMedGoogle Scholar
  5. 5.
    Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J (2000) Clinical signs and symptoms predicting influenza infection. Arch Inter Med 160:3243–3247.CrossRefGoogle Scholar
  6. 6.
    Schmid-Hempel P (2009) Immune defence, parasite evasion strategies and their relevance for ‘macroscopic phenomena’ such as virulence. Philos Trans R Soc Lond 364:85–98CrossRefGoogle Scholar
  7. 7.
    Winther B, Farr B, Turner RB, Hendley JO, Gwaltney JM, Jr, Mygind N (1984) Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl 413: 19–24Google Scholar
  8. 8.
    Smith A, Thomas M, Kent J, Nicholson K (1998) Effects of the common cold on mood and performance. Psychoneuroendocrinology 23:733–739CrossRefPubMedGoogle Scholar
  9. 9.
    Weiss RA (2002) Virulence and pathogenesis. Trends Microbiol 10:314–317CrossRefPubMedGoogle Scholar
  10. 10.
    Eccles R (2005) Asymptomatic spread of flu is not proved. BMJ 331:1145CrossRefPubMedGoogle Scholar
  11. 11.
    Turner RB, Hendley JO (2005) Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother 56:805–807CrossRefPubMedGoogle Scholar
  12. 12.
    Turner RB (1997) Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 78:531–539PubMedGoogle Scholar
  13. 13.
    Hendley JO (1998) The host response, not the virus, causes the symptoms of the common cold. Clin Infect Dis 26:847–848CrossRefPubMedGoogle Scholar
  14. 14.
    Beutler B (2003) Science review: Key inflammatory and stress pathways in critical illness — The central role of the Toll-like receptors. Crit Care 7:39–46CrossRefPubMedGoogle Scholar
  15. 15.
    Exton MS (1997) Infection-induced anorexia: active host defence strategy. Appetite 29:369–383CrossRefPubMedGoogle Scholar
  16. 16.
    Eccles R (2000) Pathophysiology of nasal symptoms. Am J Rhinol 14:335–338CrossRefPubMedGoogle Scholar
  17. 17.
    Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichenstein LM, Naclerio RM (1988) Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 173:613–616Google Scholar
  18. 18.
    Shibayama Y, Skoner D, Suehiro S, Konishi JE, Fireman P, Kaplan AP (1996) Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology 33:311–313CrossRefPubMedGoogle Scholar
  19. 19.
    Conti B, Tabarean I, Andrei C, Bartfai T (2004) Cytokines and fever. Front Biosci 9:1433–1449CrossRefPubMedGoogle Scholar
  20. 20.
    Georgitis JW (1993) Nasopharyngitis, pharyngitis, and tonsillitis. Immunol Allergy Clin North Am 13:109–118Google Scholar
  21. 21.
    Rees GL, Eccles R (1994) Sore throat following nasal and oropharyngeal bradykinin challenge. Acta Otolaryngol 114:311–314CrossRefPubMedGoogle Scholar
  22. 22.
    Eccles R, Loose I, Jawad M, Nyman L (2003) Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med 4:118–124CrossRefPubMedGoogle Scholar
  23. 23.
    Eccles R (2006) Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther 31:309–319CrossRefPubMedGoogle Scholar
  24. 24.
    Winther B, Gwaltney JM, Mygind N, Turner RB, Hendley O (1986) Sites of rhinovirus recovery after point inoculation of the upper airway. J Am Med Assoc 256:1763–1767CrossRefGoogle Scholar
  25. 25.
    Leung AKC, Robson WLM (1994) Sneezing. J Otolaryngol 23:125–129PubMedGoogle Scholar
  26. 26.
    Mygind N, Secher C, Kirkegaard J (1983) Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl 128: 16–20Google Scholar
  27. 27.
    Askenasy JJM (1990) The photic sneeze. Postgrad Med J 66:892–893CrossRefPubMedGoogle Scholar
  28. 28.
    Whitman BW, Packer RJ (1993) The photic sneeze: Literature review and discussion. Neurology 43:868–871PubMedGoogle Scholar
  29. 29.
    Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT (1996) Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 125:89–97PubMedGoogle Scholar
  30. 30.
    Eccles R, Vancauwenberge P, Tetzloff W, Borum P (1995) A clinical study to evaluate the efficacy of the antihistamine doxylamine succinate in the relief of runny nose and sneezing associated with upper respiratory-tract infection. J Pharm Pharmacol 47:990–993PubMedGoogle Scholar
  31. 31.
    Gwaltney JM, Winther B (1994) Symposium on rhinovirus pathogenesis. Acta Otolaryngol (Stockholm) Suppl 413: 45pGoogle Scholar
  32. 32.
    Eccles R (1983) Physiology of nasal secretion. Eur J Respir Dis 62:115–119Google Scholar
  33. 33.
    Eccles R, Pedersen A, Regberg D, Tulento H, Borum P, Stjarne P (2007) Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol 21:40–45CrossRefPubMedGoogle Scholar
  34. 34.
    Murray S, Del Mar C, O’Rourke P (2000) Predictors of an antibiotic prescription by GPs for respiratory tract infections: A pilot. Fam Pract 17:386–388CrossRefPubMedGoogle Scholar
  35. 35.
    Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ (2001) Assessment of airway neutrophils by sputum colour: Correlation with airways inflammation. Thorax 56:366–372CrossRefPubMedGoogle Scholar
  36. 36.
    Arroll B, Kenealy T (2005) Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews (Online): CD000247Google Scholar
  37. 37.
    Davis SS, Eccles R (2004) Nasal congestion: Mechanisms, measurement and medications. Core information for the clinician. Clin Otolaryngol 29:659–666CrossRefPubMedGoogle Scholar
  38. 38.
    Eccles R (2000) Nasal airflow in health and disease. Acta Otolaryngol (Stockholm) 120:580–595CrossRefGoogle Scholar
  39. 39.
    Eccles R, Reilly M, Eccles KSJ (1996) Changes in the amplitude of the nasal cycle associated with symptoms of acute upper respiratory tract infection. Acta Otolaryngol 116:77–81CrossRefPubMedGoogle Scholar
  40. 40.
    Malcolmson KG (1959) The vasomotor activities of the nasal mucous membrane. J Laryngol Otol 37:73–98Google Scholar
  41. 41.
    Eccles R (1983) Sympathetic control of nasal erectile tissue. Eur J Respir Dis 64:150–154Google Scholar
  42. 42.
    Lacroix JS, Stjarne P, Anggard A, Lundberg JM (1989) Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y. Acta Physiol Scand 135:17–28CrossRefPubMedGoogle Scholar
  43. 43.
    Eccles R, Eriksson M, Garreffa S, Chen SC (2008) The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol 22:491–496CrossRefPubMedGoogle Scholar
  44. 44.
    Eccles R, Jawad MS, Angello JT, Druce HM (2005) Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol 19:25–31PubMedGoogle Scholar
  45. 45.
    Clarke JD, Eccles R (2005) Paradoxical sensation of nasal airflow in patients with common cold. Are we measuring the correct modality? Acta Otolaryngol 125:1307–1311CrossRefPubMedGoogle Scholar
  46. 46.
    Gwaltney JM, Phillips CD, Miller RD, Riker DK (1994) Computed tomographic study of the common cold. N Engl J Med 330:25–30CrossRefPubMedGoogle Scholar
  47. 47.
    Falck B, Svanholm H, Aust R, Backlund L (1989) The relationship between body posture and pressure in occluded maxillary sinus of man. Rhinology 27: 161–167PubMedGoogle Scholar
  48. 48.
    Whittet HB (1992) Infraorbital nerve dehiscence: The anatomic cause of maxillary sinus “vacuum headache”? Otolaryngol Head Neck Surg 107:21–28PubMedGoogle Scholar
  49. 49.
    Falck B, Svanholm H, Aust R, Backlund L (1990) Blood flow and pulse amplitude in the mucosa of the human maxillary sinus in relation to body posture. Rhinology 28:169–176PubMedGoogle Scholar
  50. 50.
    Ayub M, Thale AB, Hedderich J, Tillmann BN, Paulsen FP (2003) The cavernous body of the human efferent tear ducts contributes to regulation of tear outflow. Invest Ophthalmol Vis Sci 44:4900–4907CrossRefPubMedGoogle Scholar
  51. 51.
    Paulsen F, Hallmann U, Paulsen J, Thale A (2000) Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism. J Anat 197:177–187CrossRefPubMedGoogle Scholar
  52. 52.
    Hadjikoutis S, Eccles R, Wiles CM (2000) Coughing and choking in motor neuron disease. J Neurol Neurosurg Psychiatry 68:601–604CrossRefPubMedGoogle Scholar
  53. 53.
    Eccles R, Lee PC (2004) Cough induced by airway vibration as a model of airway hyperreactivity in patients with acute upper respiratory tract infection. Pulm Pharmacol Ther 17:337–342CrossRefPubMedGoogle Scholar
  54. 54.
    Jacoby DB (2004) Pathophysiology of airway viral infections. Pulm Pharmacol Ther 17:333–336CrossRefPubMedGoogle Scholar
  55. 55.
    Lee P, Cotterill-Jones C, Eccles R (2002) Voluntary control of cough. Pulm Pharmacol Ther 15:317–320CrossRefPubMedGoogle Scholar
  56. 56.
    Davenport PW (2008) Urge-to-cough: What can it teach us about cough? Lung 186 (Suppl 1):S107–111CrossRefGoogle Scholar
  57. 57.
    Widdicombe J, Eccles R, Fontana G (2006) Supramedullary influences on cough. Respir Physiol Neurobiol 152:320–328CrossRefPubMedGoogle Scholar
  58. 58.
    Simonyan K, Saad ZS, Loucks TM, Poletto CJ, Ludlow CL (2007) Functional neuroanatomy of human voluntary cough and sniff production. Neuro Image 37:401–409PubMedGoogle Scholar
  59. 59.
    Hutchings HA, Eccles R, Smith AP, Jawad M (1993) Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections. Eur Respir J 6:1449–1454PubMedGoogle Scholar
  60. 60.
    Hutchings HA, Morris S, Eccles R, Jawad M (1993) Voluntary suppression of cough induced by inhalation of capsaicin in healthy volunteers. Respir Med 87: 379–382CrossRefPubMedGoogle Scholar
  61. 61.
    Eccles R (2006) Mechanisms of the placebo effect of sweet cough syrups. Respir Physiol Neurobiol 152:340–348CrossRefPubMedGoogle Scholar
  62. 62.
    Smith RS (1992) The cytokine theory of headache. Med Hypotheses 39:168–174CrossRefPubMedGoogle Scholar
  63. 63.
    Gold R, Rieckmann P, Chang P, Abdalla J (2005) The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple selerosis: 4-year data from the PRISMS study. Eur J Neurol 12:649–656CrossRefPubMedGoogle Scholar
  64. 64.
    van Zonneveld M, Flink HJ, Verhey E, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G et al. (2005) The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: Predictive factors for dose reduction and treatment discontinuation. Aliment Pharmacol Ther 21: 1163–1171CrossRefPubMedGoogle Scholar
  65. 65.
    Bo SH, Davidsen EM, Gulbrandsen P, Dietrichs E, Bovim G, Stovner LJ, White LR (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 29:365–372CrossRefPubMedGoogle Scholar
  66. 66.
    Helman CG (1978) “Feed a cold, starve a fever”. Folk models of infection in an English suburban community, and their relation to medical treatment. Cult Med Psychiatry 2:107–137CrossRefPubMedGoogle Scholar
  67. 67.
    Sanu A, Eccles R (2008) The effects of a hot drink on nasal airflow and symptoms of common cold and flu. Rhinology 46:271–275PubMedGoogle Scholar
  68. 68.
    Guieu JD, Hellon RF (1980) The chill sensation in fever. Pflugers Arch 384: 103–104CrossRefPubMedGoogle Scholar
  69. 69.
    Cabanac M (1990) Phylogeny of fever. In: J Bligh, K Voigt (eds): Thermoreception and temperature regulation. Springer, Berlin, 284–296Google Scholar
  70. 70.
    Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P et al. (2003) Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289:2801–2809CrossRefPubMedGoogle Scholar
  71. 71.
    Leon LR (2002) Invited review: Cytokine regulation of fever: Studies using gene knockout mice. J Appl Physiol 92:2648–2655PubMedGoogle Scholar
  72. 72.
    Netea MG, Kullberg BJ, Van der Meer JW (2000) Circulating cytokines as mediators of fever. Clin Infect Dis 31 (Suppl 5): S178–184CrossRefGoogle Scholar
  73. 73.
    Blatteis CM (2007) The onset of fever: New insights into its mechanism. Prog Brain Res 162:3–14CrossRefPubMedGoogle Scholar
  74. 74.
    Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153–160CrossRefPubMedGoogle Scholar
  75. 75.
    Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L, Davenport T, Wakefield D, Hickie I, Lloyd A (2004) Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychological Medicine 34:1289–1297CrossRefPubMedGoogle Scholar
  76. 76.
    Herzog C, Berger R, Fernex M, Friesecke K, Havas L, Just M, Dubach UC (1986) What dose of intranasal interferon for the common cold? Lancet 1: 1089–1090CrossRefPubMedGoogle Scholar
  77. 77.
    Gwaltney JM, Jr, Winther B, Patrie JT, Hendley JO (2002) Combined antiviralantimediator treatment for the common cold. J Infect Dis 186:147–154CrossRefPubMedGoogle Scholar
  78. 78.
    Schaefer M, Schmidt F, Neumer R, Scholler G, Schwarz M (2002) Interferonalpha, cytokines and possible implications for mood disorders. Bipolar Disord 4 (Suppl 1):111–113CrossRefPubMedGoogle Scholar
  79. 79.
    Miller AH (2009) Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23:149–158CrossRefPubMedGoogle Scholar
  80. 80.
    Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ, Vogt CJ, Massung B, Miller AH (2009) Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 65:296–303CrossRefPubMedGoogle Scholar
  81. 81.
    McCarthy DO (2000) Cytokines and the anorexia of infection: Potential mechanisms and treatments. Biol Res Nurs 1:287–298CrossRefPubMedGoogle Scholar
  82. 82.
    Brobeck JR (1948) Food intake as a mechanism of temperature regulation. Yale J Biol Med 20:545–552PubMedGoogle Scholar
  83. 83.
    Mahoney T, Ball P (2002) Common respiratory tract infections as psychological entities: A review of the mood and performance effects of being ill. Aust Psychol 37:86–94CrossRefGoogle Scholar
  84. 84.
    Baracos V, Rodemann HP, Dinarello CA, Goldberg AL (1983) Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 308:553–558PubMedCrossRefGoogle Scholar
  85. 85.
    Kotler DP (2000) Cachexia. Ann Intern Med 133:622–634PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2009

Authors and Affiliations

  • Ronald Eccles
    • 1
  1. 1.Common Cold Centre, Cardiff School of BiosciencesCardiff UniversityCardiffUK

Personalised recommendations